Page last updated: 2024-11-02

moxonidine and Focal Segmental Glomerulosclerosis

moxonidine has been researched along with Focal Segmental Glomerulosclerosis in 2 studies

moxonidine: structure given in first source

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amann, K1
Rump, LC1
Simonaviciene, A1
Oberhauser, V1
Wessels, S1
Orth, SR1
Gross, ML1
Koch, A1
Bielenberg, GW1
VAN Kats, JP1
Ehmke, H1
Mall, G2
Ritz, E2
Irzyniec, T1
Greber, D1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System[NCT03109795]Phase 430 participants (Actual)Interventional2017-04-10Terminated (stopped due to Funding ended)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for moxonidine and Focal Segmental Glomerulosclerosis

ArticleYear
Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subtotally nephrectomized rats.
    Journal of the American Society of Nephrology : JASN, 2000, Volume: 11, Issue:8

    Topics: Albuminuria; Angiotensin II; Animals; Antihypertensive Agents; Glomerulosclerosis, Focal Segmental;

2000
Beneficial effect of nifedipine and moxonidine on glomerulosclerosis in spontaneously hypertensive rats. A micromorphometric study.
    American journal of hypertension, 1992, Volume: 5, Issue:7

    Topics: Animals; Antihypertensive Agents; Blood Vessels; Glomerulosclerosis, Focal Segmental; Imidazoles; Ki

1992